Latest Earnings Analysis
-
Amylix Pharmaceuticals (AMLX) Q1 2024: 70% Workforce Cut Resets Pipeline Focus, Cash Runway Extends to 2026
May 09, 2024 · AMLX
-
ACRE Q1 2024: Non-Accrual Loan Balance Cut by $133M as Office Exposure Drops 8%
May 09, 2024 · ACRE
-
AMN Healthcare (AMN) Q1 2024: Travel Nurse Revenue Down 44% as Labor Reset Deepens, Tech and Diversification Buffer Margins
May 09, 2024 · AMN
-
Arlo (ARLO) Q1 2024: Service Revenue Jumps 29% as Paid Accounts Surge, Margin Model Shifts
May 09, 2024 · ARLO
-
American Vanguard (AVD) Q1 2024: Operating Income Surges 87% as Transformation Costs Offset Near-Term Gains
May 09, 2024 · AVD
-
Avino Silver & Gold Mines (ASM) Q1 2024: Cash Costs Drop to $14.89, Paving Way for La Preciosa Ramp
May 09, 2024 · ASM
-
Acacia Research (ACTG) Q1 2024: IP Licensing Jumps 224% as Benchmark Oil Asset Set to Drive $50M Cash Flow
May 09, 2024 · ACTG
-
Akebia (AKBA) Q1 2024: Field Team Expansion Up 55% Accelerates Vafseo Launch Traction
May 09, 2024 · AKBA
-
BHR Q1 2024: $165M Asset Sale, Luxury Resorts Outpace Underwriting as Capital Plan Accelerates
May 09, 2024 · BHR
-
Altimmune (ALT) Q1 2024: R&D Spend Rises 25% as Phase 3 Obesity Program Readies for Expansion
May 09, 2024 · ALT
-
BTAI Q1 2024: Egalmi Revenue Up 182% as Late-Stage Agitation Trials Set Dual Value Path
May 09, 2024 · BTAI
-
ARGX Q1 2024: Vivgard Patient Base Surpasses 10,000 as Subcutaneous Uptake Accelerates 34%
May 09, 2024 · ARGX
-
ARQ Q1 2024: GAC Contract Secures 20% Capacity, Regulatory Tailwind Signals Multi-Year Demand Surge
May 09, 2024 · ARQ
-
Amplitude (AMPL) Q1 2024: 19% Multi-Product Adoption Signals Platform Expansion Amid Churn Reset
May 09, 2024 · AMPL
-
BioLife Solutions (BLFS) Q1 2024: GCI Divestiture Drives 13% Pro Forma EBITDA Margin, Refocuses on High-Growth Core
May 09, 2024 · BLFS
-
Amprius Technologies (AMPX) Q1 2024: Customer Shipments Double as Sitecore Drives Capacity Scale
May 09, 2024 · AMPX
-
Array Technologies (ARRY) Q1 2024: $2.1B Order Book Extends Visibility as Margins Hold Amid ASP Deflation
May 09, 2024 · ARRY
-
Arrowhead Pharmaceuticals (ARWR) Q2 2024: R&D Spend Rises 29% as Cardiometabolic Pipeline Accelerates Toward Commercialization
May 09, 2024 · ARWR
-
Advantage Solutions (ADV) Q1 2024: Experiential Services Revenue Jumps 21% as Portfolio Simplification Accelerates
May 09, 2024 · ADV
-
Alarm.com (ALRM) Q1 2024: Growth Segment Hits 31% of SaaS Revenue, AI and Commercial Expansion Drive Outlook Raise
May 09, 2024 · ALRM
-
Akamai (AKAM) Q1 2024: Security and Compute Now 64% of Revenue as Delivery Declines Accelerate
May 09, 2024 · AKAM
-
Amplify Energy (AMPY) Q1 2024: Sinking Fund Payments Cut by $7M, Unlocking Cash Flow Flexibility
May 09, 2024 · AMPY
-
Black Rifle Coffee (BRCC) Q1 2024: Wholesale Soars 51% as Supply Chain Overhaul Lifts Margins
May 09, 2024 · BRCC
-
CarGurus (CARG) Q1 2024: Marketplace Bookings Jump 28% as Subscription Model Drives Margin Expansion
May 09, 2024 · CARG
-
Allient (ALNT) Q1 2024: Industrial Segment Hits 45% of Sales as Brand Consolidation and Cost Actions Target $10M+ EBITDA Gain
May 09, 2024 · ALNT
-
AvePoint (AVPT) Q1 2024: SaaS Revenue Jumps 44%, Channel Mix and AI Readiness Drive Platform Leverage
May 09, 2024 · AVPT
-
Aviana (AVAH) Q1 2024: Preferred Payer Contracts Now Cover 40% of Managed Care Opportunity, Accelerating Margin Recovery
May 09, 2024 · AVAH
-
Babcock & Wilcox (BW) Q1 2024: Bookings Surge 97% as Backlog Hits $826M, Margin Focus Drives Outlook Upgrade
May 09, 2024 · BW
-
Afya (AFYA) Q1 2024: Margin Expansion Surges 500bps in Medical Practice Solutions Amid Ecosystem Integration
May 09, 2024 · AFYA
-
APYX Q1 2024: Advanced Energy Sales Drop 23% as Capital Equipment Demand Stalls
May 09, 2024 · APYX
-
AFC Gamma (AFCG) Q1 2024: 20% Portfolio Yield Positions Lender for Cannabis Upside
May 09, 2024 · AFCG
-
Archer Aviation (ACHR) Q1 2024: $3.5B Backlog Anchors Capital-Light Scale as Midnight Nears Transition
May 09, 2024 · ACHR
-
Brilliant Earth (BRLT) Q1 2024: Gross Margin Expands 500bps as Brand Withstands Industry Discounting
May 09, 2024 · BRLT
-
Achieve Life Sciences (ACHV) Q1 2024: $124M Financing Secured as NDA Pathway Clears for Cytosinicline
May 09, 2024 · ACHV
-
BK Technologies (BKTI) Q1 2024: Backlog Grows 19% as Asset-Light Model and Multiband Radios Drive Margin Expansion
May 09, 2024 · BKTI
-
American Coastal Insurance (ACIC) Q1 2024: Quota Share Cut to 20% Unlocks Premium Retention Upside
May 09, 2024 · ACIC
-
ACV Auctions (ACVA) Q1 2024: Adjusted EBITDA Margin Expands 800bps as Marketplace Leverage Accelerates
May 08, 2024 · ACVA
-
Cheesecake Factory (CAKE) Q1 2024: Four-Wall Margins Expand 100bps as Operational Execution Stabilizes
May 08, 2024 · CAKE
-
Blue Bird (BLBD) Q2 2024: Backlog Surges 30% as EV Mix Drives Margin Expansion
May 08, 2024 · BLBD
-
Airbnb (ABNB) Q1 2024: 17% Listing Growth Unlocks Supply-Led Affordability and Brand Expansion
May 08, 2024 · ABNB
-
AWR Q1 2024: $24M Water Rate Hike Anchors Regulated Utility Growth Trajectory
May 08, 2024 · AWR
-
Acadia Pharmaceuticals (ACAD) Q1 2024: Debut Drives 74% Revenue Surge as Persistency Tops Clinical Benchmarks
May 08, 2024 · ACAD
-
Brookdale (BKD) Q1 2024: Occupancy Up 160bps as Margin Recovery Nears Pre-Pandemic Peak
May 08, 2024 · BKD
-
Blackstone Secured Lending (BXSL) Q1 2024: $1.2B Commitments Signal Portfolio Growth Acceleration
May 08, 2024 · BXSL
-
Accel Entertainment (ACEL) Q1 2024: Location Count Rises 5.1% as CapEx Normalizes
May 08, 2024 · ACEL
-
AMC (AMC) Q1 2024: Market Share Rises 70bps as Per-Patron Profit Hits 44% Above 2019
May 08, 2024 · AMC
-
Allbirds (BIRD) Q1 2024: Gross Margin Expands 680bps as Distributor Shift and Store Closures Reshape Model
May 08, 2024 · BIRD
-
ACMR Q1 2024: Single Wafer Cleaning Surges 199% as Global Diversification Accelerates
May 08, 2024 · ACMR
-
Alight (ALIT) Q1 2024: BPAS Revenue Jumps 22% as Recurring Model Drives Margin Reset
May 08, 2024 · ALIT
-
AQST Q1 2024: $77.5M Raise Extends Runway, Accelerates Anafilm and Libervant Commercial Prep
May 08, 2024 · AQST